Published in Drug Week, February 6th, 2004
Valsartan patients also incurred lower total medical costs, an average $32,412 (26%) compared with amlodipine-treated patients.
D.G. Smith and colleagues at the University of Michigan published their findings in the January/February 2004 issue of the Journal of Managed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.